chr1-47416334-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_012186.3(FOXE3):c.19A>G(p.Met7Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000269 in 1,373,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_012186.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXE3 | NM_012186.3 | c.19A>G | p.Met7Val | missense_variant | 1/1 | ENST00000335071.4 | NP_036318.1 | |
LINC01389 | NR_126355.1 | n.29-6433T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXE3 | ENST00000335071.4 | c.19A>G | p.Met7Val | missense_variant | 1/1 | 6 | NM_012186.3 | ENSP00000334472.2 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150824Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000278 AC: 34AN: 1222198Hom.: 0 Cov.: 31 AF XY: 0.0000267 AC XY: 16AN XY: 600164
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150824Hom.: 0 Cov.: 32 AF XY: 0.0000272 AC XY: 2AN XY: 73524
ClinVar
Submissions by phenotype
Congenital primary aphakia;C1862839:Anterior segment dysgenesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1007471). This variant has not been reported in the literature in individuals affected with FOXE3-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.005%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 7 of the FOXE3 protein (p.Met7Val). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2024 | The c.19A>G (p.M7V) alteration is located in exon 1 (coding exon 1) of the FOXE3 gene. This alteration results from a A to G substitution at nucleotide position 19, causing the methionine (M) at amino acid position 7 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at